T.‐C. Wu
Impact in
- Immunology top 0.1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Epidemiology top 0.2%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
Papers in
- Immunology 188
- Immunotherapy and Immune Responses 171
- Immune Cell Function and Interaction 36
- Epidemiology 106
- Cervical Cancer and HPV Research 78
- Hepatitis B Virus Studies 43
- Co-authors
- Chien‐Fu Hung (185 shared papers)Drew M. Pardoll (16 shared papers)Richard B.S. Roden (40 shared papers)Liangmei He (40 shared papers)Morris Ling (22 shared papers)Shiwen Peng (44 shared papers)Wen‐Fang Cheng (20 shared papers)Archana Monie (29 shared papers)
- Journals
- Journal of Biomedical Science (25 papers)Gene Therapy (20 papers)Human Gene Therapy (12 papers)Vaccine (12 papers)Cancer Research (11 papers)
- Partner nations
- United StatesTaiwanSouth Korea
In The Last Decade
T.‐C. Wu
269 papers receiving 13.8k citations
T.‐C. Wu's Hit Papers
Peers
Comparison fields: 5 of 156
- Immunology 8.2k
- Epidemiology 4.7k
- Oncology 3.4k
- Biotechnology 660
- Molecular Biology 4.8k
Countries citing papers authored by T.‐C. Wu
This map shows the geographic impact of T.‐C. Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.‐C. Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.‐C. Wu more than expected).
Fields of papers citing papers by T.‐C. Wu
This network shows the impact of papers produced by T.‐C. Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.‐C. Wu. The network helps show where T.‐C. Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside T.‐C. Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 275 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Hit paper breakdown → | 1996 | 870 |
| 2 | Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. | 2000 | 303 |
| 3 | 1995 | 287 | |
| 4 | 2020 | 281 | |
| 5 | 2005 | 274 | |
| 6 | Cervical Cancer Immunotherapy: Facts and Hopes Hit paper breakdown → | 2021 | 222 |
| 7 | 2006 | 221 | |
| 8 | 2001 | 219 | |
| 9 | 2001 | 215 | |
| 10 | Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. | 1991 | 215 |
| 11 | 2014 | 212 | |
| 12 | 2014 | 197 | |
| 13 | 1999 | 181 | |
| 14 | 1995 | 177 | |
| 15 | 2008 | 164 | |
| 16 | 1995 | 160 | |
| 17 | 2003 | 153 | |
| 18 | 2012 | 152 | |
| 19 | 2016 | 151 | |
| 20 | 2004 | 147 |
About T.‐C. Wu
T.‐C. Wu is a scholar working on Immunology, Epidemiology, Molecular Biology, Oncology and Genetics, having authored 275 papers that have together received 14.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (171 papers), Cervical Cancer and HPV Research (78 papers), Hepatitis B Virus Studies (43 papers), Cancer Immunotherapy and Biomarkers (40 papers), Virus-based gene therapy research (36 papers), Immune Cell Function and Interaction (36 papers), vaccines and immunoinformatics approaches (34 papers) and RNA Interference and Gene Delivery (28 papers). The work is most often cited by research in Immunology (8.2k citations), Epidemiology (4.7k citations), Oncology (3.4k citations), Biotechnology (660 citations) and Molecular Biology (4.8k citations). T.‐C. Wu has collaborated with scholars based in United States, Taiwan and South Korea. Frequent co-authors include Chien‐Fu Hung, Drew M. Pardoll, Richard B.S. Roden, Liangmei He, Morris Ling, Shiwen Peng, Wen‐Fang Cheng, Archana Monie, Sara I. Pai and J. Thomas August. Their work appears in journals such as Journal of Biomedical Science, Gene Therapy, Human Gene Therapy, Vaccine and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.